Browse the evidence

Total daily energy expenditure (TEE) in traditional hunter-gatherers is not significantly different from that of Western populations when controlling for body size, challenging the model that decreased energy expenditure is a primary driver of modern obesity.

Do not assume that being sedentary automatically means your body burns significantly fewer calories than an active person of the same size. Your metabolism is robust and adapts to your body size and lean mass. Focusing solely on 'burning calories' through exercise may be less effective than managing energy intake, as your body's total daily expenditure is largely constrained by your physiology rather than just your activity level.

Wrist-worn fitness monitors (Apple Watch, Fitbit Charge HR, Samsung Gear S, Mio Alpha) provide accurate heart rate measurements but significantly underestimate energy expenditure, rendering them unreliable for weight management via energy balance tracking.

Do not rely on wrist-worn fitness trackers to dictate your calorie intake for weight loss. While they are good at tracking heart rate, they consistently underestimate calories burned by up to 43%. Use them for general activity trends, but do not use the calorie numbers to justify eating back exercise calories.

Ectopic fat deposition in the liver and pancreatic islets drives the pathogenesis of type 2 diabetes through two vicious cycles: Cycle A (hepatic) causing hepatic insulin resistance, and Cycle B (islet) causing beta-cell dysfunction.

Type 2 diabetes is driven by fat accumulating in your liver and pancreas, not just by your pancreas 'failing'. By reducing overall calorie intake, you can remove this fat and break the cycle, potentially reversing the disease if caught early.

Gut microbiota-derived short-chain fatty acids (SCFAs), specifically acetate, propionate, and butyrate, regulate host energy homeostasis and metabolic health by acting as signaling molecules on G-protein-coupled receptors (GPR41/43) and influencing hormone secretion (GLP-1, PYY).

To support metabolic health, prioritize diets rich in whole plant fibers. This feeds gut bacteria to produce short-chain fatty acids (SCFAs) like butyrate and acetate. These SCFAs signal your body to regulate appetite and insulin sensitivity via specific receptors, helping to prevent metabolic syndrome and obesity.

Low-GI diets are not directly associated with weight reduction, despite popular belief.

Do not rely on low-GI labels alone for weight loss. While low-GI foods may help manage blood sugar, they do not guarantee weight loss. Focus on total calorie intake and overall diet quality.

Long-term administration of the CB1 receptor antagonist rimonabant (SR141716) reverses diet-induced obesity in mice by enhancing lipolysis and increasing energy expenditure through futile cycling, rather than solely through reduced food intake.

This research suggests that sustained fat loss can be driven by increasing the body's energy expenditure and fat burning (lipolysis) rather than just eating less. The drug rimonabant achieved this by activating metabolic pathways in fat tissue. Note: Rimonabant was withdrawn from the market due to safety concerns; this mechanism highlights the potential of targeting energy expenditure pathways.

Genetic ablation of lateral hypothalamic area (LHA) glutamatergic neurons increases daily caloric intake and body weight gain in mice fed a high-fat diet without altering general locomotor activity.

This research identifies a specific neural circuit (LHA glutamatergic neurons projecting to the lateral habenula) that acts as a brake on overeating palatable, high-fat foods. When this brake is removed, mice consume more calories and gain weight, even without changes in movement. This suggests that obesity may involve specific neural circuit failures rather than just a lack of willpower or general metabolic slowdown.

Sarcopenia is mechanistically driven by mitochondrial bioenergetic dysfunction, characterized by downregulated PGC-1α/ERRα signaling, reduced oxidative phosphorylation, and low NAD+ levels, rather than primarily by inflammation or denervation.

This research highlights that muscle loss in older adults is fundamentally linked to mitochondrial energy failure and low NAD+ levels, distinct from general inflammation or nerve issues. While this paper does not prescribe a specific exercise or supplement protocol, it strongly suggests that interventions aiming to boost mitochondrial function (e.g., through exercise which stimulates PGC-1α, or potential NAD+ precursors) may be more effective for treating pathological sarcopenia than approaches focused solely on protein intake or anti-inflammatories.

Obesity and excess caloric intake lead to immune dysfunction by causing leptin resistance and downregulating immune responsiveness, increasing susceptibility to infections.

Maintaining a healthy weight is crucial for immune function. Obesity is linked to reduced white blood cell activity and increased inflammation. While weight loss is beneficial, understand that the biological changes (like leptin resistance) take time to reverse, and immune health is also influenced by the quality of fats and sugars you consume.

Rising income levels in developing countries lead to a 'nutrition transition' characterized by sedentary lifestyles and high-calorie diets, causing a rapid increase in childhood obesity and type 2 diabetes.

As countries develop and people earn more, they often consume more processed foods and move less. This leads to rapid increases in childhood obesity and diabetes. To counter this, communities and families must prioritize physical activity and healthy food choices even as incomes rise.

L-carnitine supplementation does not significantly improve exercise performance or reduce fatigue in healthy individuals, despite its role in fatty acid transport.

If you are healthy and exercising, taking L-carnitine supplements will not make you perform better or feel less tired. It is safe, but it does not work as a performance enhancer for you.

Modern obesogenic environments override physiological homeostatic controls by overwhelming evolutionarily conserved cognitive, reward, and emotional neural systems that evolved to secure food in sparse conditions.

Recognize that your brain is wired to seek high-calorie foods because of evolutionary history, not just lack of will. In a modern environment with constant food availability, this drive is maladaptive. Effective management requires acknowledging these powerful neural drivers (reward, stress, habit) and structuring your environment to reduce cues, rather than relying solely on conscious calorie counting.

Knocking out the ACC2 gene in mice increases continuous fat oxidation, which raises total energy expenditure and reduces fat mass without causing insulin resistance.

This research suggests that strategies which continuously promote fat oxidation (like specific genetic targets or metabolic states) can increase overall energy expenditure and reduce fat mass. However, this was achieved through genetic modification in mice, not a standard human intervention, so direct application requires caution.

Declining brown adipose tissue (BAT) activity with age contributes to reduced energy expenditure and increased obesity risk, mediated by reduced sympathetic output and increased FOXA3 transcription factor.

Brown fat, which burns calories to generate heat, becomes less active as you age. This is partly due to reduced nerve signals and changes in gene expression. While you cannot easily reverse this biological change, maintaining physical activity may help stimulate remaining brown fat function.

Colonic SCFA mixtures attenuate whole-body lipolysis, indicated by decreased fasting free glycerol concentrations.

SCFAs may help reduce the release of fatty acids from fat cells (lipolysis). While this might sound counterintuitive for weight loss, it can help prevent fat from accumulating in the liver and muscles, improving insulin sensitivity. Focus on fiber intake to support this process.

Body weight and adiposity settle at a level determined by environmental factors (intake) and passive physical constraints (expenditure proportional to mass), without an active defended set point.

Your weight settles where your environment allows it to. If you live in an environment with high-calorie food and low physical activity, your weight will settle higher. To change your weight, you must change the environmental inputs (food availability, portion sizes) and outputs (physical activity), as your body passively adjusts expenditure to match the new mass.

Brown adipose tissue (BAT) glucose uptake during cold exposure does not significantly contribute to systemic glucose clearance or thermogenesis because most taken-up glucose is metabolized into lactate or used for glyceroneogenesis rather than mitochondrial oxidation.

Cold exposure activates brown fat, but don't expect it to significantly lower your blood sugar or burn calories through glucose oxidation. The glucose taken up is mostly recycled into lactate or fat, not burned for heat. Focus on other mechanisms if targeting glucose metabolism.

Intracellular triglyceride (TG) lipolysis-derived fatty acids are the primary energy source for brown adipose tissue (BAT) thermogenesis upon cold activation, although circulating fatty acids can substitute if intracellular stores are unavailable.

Cold exposure triggers brown fat to burn stored fat inside the cells for heat. This is the main mechanism, though it can switch to blood fat if needed.

Adding physiological measures such as heart rate to accelerometer data does not significantly improve the estimation of energy expenditure compared to using accelerometers alone.

If your goal is to track energy expenditure accurately, a standard accelerometer is likely sufficient. You do not need to invest in expensive multi-sensor devices that combine heart rate monitoring, as current evidence shows they do not significantly improve accuracy over accelerometers alone. Focus on consistent wear time rather than device complexity.

Brown adipose tissue (BAT) activity in adults is negatively correlated with body mass index (BMI) and body fat percentage, and is absent or significantly reduced in obese and elderly populations.

If you are obese or older, your brown fat activity may be lower, making it harder to rely on cold exposure for weight loss. However, this doesn't mean you can't benefit from other aspects of energy expenditure. Focus on overall energy balance, as even small increases in expenditure can have long-term effects.

Higher body weight does not necessarily result in a lower Physical Activity Level (PAL); obese individuals often have similar or higher activity-induced energy expenditure (AEE) than lean individuals due to higher movement costs, despite moving less frequently.

Do not assume that because you are overweight, you burn fewer calories during activity than a lean person. Your body burns more energy to move your mass, so your total activity energy expenditure might be similar to someone leaner who moves more frequently. Weight loss requires creating a deficit, not just assuming you 'don't move enough' compared to others.

Acquired obesity in humans is associated with a significant reduction (approx. 47%) in mitochondrial DNA (mtDNA) copy number in subcutaneous adipose tissue, which correlates with insulin resistance and liver fat.

This study found that people with acquired obesity have significantly fewer mitochondria in their fat tissue. This structural change may contribute to insulin resistance and liver fat. While this doesn't prescribe a specific diet, it highlights that metabolic health involves more than just total calories; the specific handling of amino acids by fat tissue matters.

Age-related decline in skeletal muscle mitochondrial ATP production rates (MAPR) is independent of adiposity and insulin sensitivity.

Maintaining a healthy weight is crucial for insulin sensitivity, but it does not prevent age-related declines in mitochondrial function. To support mitochondrial health as you age, consider strategies beyond weight management, such as exercise, which may help mitigate these intrinsic declines.

Approximately 41% of ingested fructose is converted to glucose within 2-6 hours in normal non-exercising subjects, with lower conversion rates observed in women, obese, and diabetic individuals.

If you consume fructose, expect about 40% of it to turn into glucose in your body within a few hours. This effect is weaker in women and people with diabetes or obesity.